
Biogenera
Developer of therapeutic drugs designed to provide treatment for pediatric cancer. The company's platform can identify and develop new drugs targeted at each specific therapeutic target consisting of ...
Valuation
$87.9M
Latest known
Share Price
N/A
Total Raised
$15.1M
Last Round
N/A